GSK
GSK Bolsters Oncology Portfolio With $10.6 Billion Nuvalent Acquisition in its Third Major Deal in 2026
2026-06-09
JPM 2026 Recap: Capital Markets Reopen, AI Moves to the Last Mile, Metabolic Stakes Climb
2026-01-15
GSK Successfully Acquires Clinical-Stage Company IDRx, Inc. to Enhance Cancer Treatment Options
2025-03-03
GSK’s Penmenvy Secures FDA Approval to Combat Five Major Meningococcal Serogroups Among Youth
2025-02-17
GSK Expands Arexvy Approval to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan
2024-12-02
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




